Targeting PPARalpha in Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|15|4|345-354

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.15, Iss.4, 2018-02, pp. : 345-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies

By  

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 217-228

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Prescription for Alzheimer's Disease: Targeting Hypercoagulable States

By  

Current Neurovascular Research, Vol. 12, Iss. 1, 2015-02 ,pp. : 1-3

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of ADDL-Targeting Small Molecule Drugs for Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 562-567

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease

By St. George-Hyslop P.  

Neurobiology of Disease, Vol. 7, Iss. 5, 2000-10 ,pp. : 546-548

Academic Press

Access to resources Recommend Favorite

Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimer's Disease Mechanisms

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 503-506

Bentham Science Publishers

Access to resources Recommend Favorite